Search - tctmd.com

Displaying 81 - 98 of 98

Sort: Relevancy | Date

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

News Conference News ACC 2017

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

Todd Neale

March 18, 2017

News Daily News

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

Todd Neale

March 10, 2017

Presentation SIF 2017

Debate: With Modern Generation DES, 3 – 6 months of DAPT Is All You Need

Presenter: William B. Bachinsky

March 10, 2017

Presentation SIF 2017

PCI Pharmacology in 2017: Understanding the Essentials

Presenter: MIchael A. Kutcher

March 09, 2017

Presentation CRT 2017

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Presenter: Chadi Alraies

February 22, 2017

News Conference News CRT 2017

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Michael O'Riordan

February 21, 2017

News Conference News CRT 2017

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

Michael O'Riordan

February 20, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

Presentation JIM 2017

BRS - A “Stillborn” Device!

Presenter: Davide Capodanno

February 08, 2017

News Daily News

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

Michael O'Riordan

February 03, 2017

Presentation Cardiovascular Interventions 2016

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Presenter: Dean J. Kereiakes

November 10, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

Presentation CCVVC 2016

Optimal Duration of DAPT: Update on DAPT Guidelines

Presenter: Roxana Mehran

June 16, 2016

Presentation CCVVC 2016

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

Presenter: Marc P. Bonaca

June 15, 2016

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Partner Content

Exploring XIENCE’s Performance in Short DAPT

November 16, 2017

Advertisement

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe

The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score

Debate: With Modern Generation DES, 3 – 6 months of DAPT Is All You Need

PCI Pharmacology in 2017: Understanding the Essentials

Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate

Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

BRS - A “Stillborn” Device!

Cobra Stent With Ultrathin Polymer Safe, Effective but Needs Testing in Tougher Patients

DAPT after Stenting: How Short When Needed and How Long When Tolerated?

Timing of DAPT Interruption and DES Thrombosis

Optimal Duration of DAPT: Update on DAPT Guidelines

Novel Anti-thrombotics in Patients with Peripheral Artery Disease

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Exploring XIENCE’s Performance in Short DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content